You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Drug Sales Trends for ELIQUIS

✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ELIQUIS (2021)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$2,315,778,183
INSIDE ANOTHER STORE	$4,401,418,877
[disabled in preview]	$6,323,820,904
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	2,654,802
INSIDE ANOTHER STORE	4,662,375
[disabled in preview]	10,350,740
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$278,855,563
MEDICARE	$8,056,533,748
[disabled in preview]	$4,725,941,632
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for ELIQUIS

Drug Units Sold Trends for ELIQUIS

Annual Sales Revenues and Units Sold for ELIQUIS

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Sign Up
Drug Name	Revenues (USD)	Units	Year
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2021
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2020
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2019
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2018
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2017
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2016
ELIQUIS	⤷ Sign Up	⤷ Sign Up	2015
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.